Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
International Journal of Molecular Sciences · 22.08.2024 · 25 (16) · 9101
DOI: 10.3390/ijms25169101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.08.2024. Verfasst von Shuxi Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Proto-Oncogene Proteins c-met, Tumor Microenvironment, Hepatocyte Growth Factor. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Non-small cell lung cancer (NSCLC) is characterized by several molecular alterations that contribute to its development and progression. These alterations include the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), human epidermal growth factor receptor 2 (HER2), and mesenchymal–epithelial transition factor (c-MET). Among these, the hepatocyte growth factor (HGF)/c-MET signaling pathway plays a crucial role in NSCLC. In spite of this, the involvement of the HGF/c-MET signaling axis in remodeling the tumor microenvironment (TME) remains relatively unexplored. This review explores the biological functions of the HGF/c-MET signaling pathway in both normal and cancerous cells, examining its multifaceted roles in the NSCLC tumor microenvironment, including tumor cell proliferation, migration and invasion, angiogenesis, and immune evasion. Furthermore, we summarize the current progress and clinical applications of MET-targeted therapies in NSCLC and discuss future research directions, such as the development of novel MET inhibitors and the potential of combination immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Shuxi Yao
Förderung
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Yao, S., Liu, X., Feng, Y., Li, Y., Xiao, X., Han, Y., & Xia, S. (2024). Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment. International Journal of Molecular Sciences, 25(16), 9101. https://doi.org/10.3390/ijms25169101
Vancouver
Yao S, Liu X, Feng Y, Li Y, Xiao X, Han Y, et al. Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment. International Journal of Molecular Sciences. 2024;25(16):9101. doi:10.3390/ijms25169101
BibTeX
@article{Yao2024,
author = {Yao, Shuxi and Liu, Xinyue and Feng, Yanqi and Li, Yiming and Xiao, Xiangtian and Han, Yuelin and Xia, Shu},
title = {Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {16},
pages = {9101},
doi = {10.3390/ijms25169101}
}
EUVIMED